Core Viewpoint - The report provides an overview of Jiangsu Feiwo Tai Nano Technology Co., Ltd.'s fundraising activities and the status of its use of raised funds, emphasizing compliance with regulatory requirements and the absence of significant risks affecting operations [1][3]. Group 1: Company Overview - Jiangsu Feiwo Tai Nano Technology Co., Ltd. has successfully completed its initial public offering, raising a total of approximately RMB 1.55 billion, with a net amount of approximately RMB 1.44 billion after deducting issuance costs [3][4]. - The company has established a management system for the use of raised funds to ensure compliance with relevant laws and regulations [6][8]. Group 2: Fundraising and Usage - As of June 30, 2025, the company has utilized approximately RMB 1.37 billion of the raised funds, with RMB 13.86 million used in the first half of 2025, leaving a balance of approximately RMB 29.82 million in the fundraising account [6][8]. - The company has not engaged in any cash management activities with idle raised funds or used excess funds for operational purposes during the reporting period [10][11]. Group 3: Compliance and Reporting - The company has adhered to the regulatory requirements for the disclosure of fundraising activities, ensuring timely and accurate reporting of the status of raised funds [11][12]. - There have been no changes to the fundraising projects or issues related to the use and disclosure of raised funds during the reporting period [11][12].

Core Insights - The company reported a revenue of 228,776,529.63 yuan for the first half of 2025, representing a year-on-year growth of 6.95% [1] - The net profit attributable to shareholders of the listed company was 16,713,493.27 yuan, showing a year-on-year increase of 7.74% [1]

Core Viewpoint - Fivotech (SH 688371, closing price: 19.19 yuan) reported a year-on-year increase in revenue and net profit for the first half of 2025, indicating positive growth trends in its financial performance [2] Financial Performance - The company's operating revenue for the first half of 2025 is approximately 229 million yuan, representing a year-on-year increase of 6.95% [2] - The net profit attributable to shareholders of the listed company is approximately 16.71 million yuan, reflecting a year-on-year increase of 7.74% [2] - Basic earnings per share stand at 0.05 yuan [2]

江苏菲沃泰纳米科技股份有限公司 关于 2025 年度"提质增效重回报"行动方案的 半年度评估报告 为响应上海证券交易所《关于开展沪市公司"提质增效重回报"专项行动的倡 议》，积极践行"以投资者为本"的上市公司发展理念，推动公司高质量发展和投 资价值提升，江苏菲沃泰纳米科技股份有限公司（以下简称"公司"）于 2025 年 5 月 22 日披露了《2025 年度"提质增效重回报"行动方案》（以下简称"《行动 方案》"）。 2025 年上半年，公司根据《行动方案》积极落实相关举措并认真评估实施 效果，公司 2025 年 8 月 14 日召开的第二届董事会第十五次会议审议通过了《关 于<公司 2025 年"提质增效重回报"行动方案的半年度评估报告>的议案》，方案 半年度实施情况具体如下： 一、聚焦主业发展，提升公司竞争力 公司是全球纳米镀膜领域技术和产业规模的领先者，在镀膜设备设计、材料 配方研制、制备工艺等方面具有技术领先优势，解决了各类电子产品轻薄化、精 细化、超低尺度化防护问题，开发出了环境友好型的纳米涂层和工艺技术，实现 了镀膜领域国产量产设备的突破，打破了智能化电子产品防护领域由国外品牌占 据的僵局，实现了 ...

证券代码：688371 证券简称：菲沃泰 公告编号：2025-039 江苏菲沃泰纳米科技股份有限公司 2025 年半年度募集资金存放与实际使用情况 的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司募集资金监管规则》（以下简称 "《监管规则》"）、《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》（以下简称"《规范运作》"）等有关法律、行政法规、部 门规章及业务规则的规定，就江苏菲沃泰纳米科技股份有限公司（以下简称 "公司"或"菲沃泰"）2025 年半年度募集资金存放与实际使用情况作如下专 项报告： 一、募集资金基本情况 （一）募集资金发行和到位情况 经中国证券监督管理委员会证监许可[2022]1078 号《关于同意江苏菲沃泰 纳米科技股份有限公司首次公开发行股票注册的批复》，同意公司首次公开发 行股票的 注册申请，公 司向社会公开 发行人民币普 通股（A 股）股 票 83,868,089 股（每股面值人民币 1 元），每股发行价 18.54 元，募集资金总额 ...

Core Viewpoint - The company reported a revenue of 229 million yuan for the first half of 2025, reflecting a year-on-year growth of 6.95% [2] - The net profit attributable to shareholders reached 16.71 million yuan, marking a year-on-year increase of 7.74% [2] - The non-recurring net profit was 8.89 million yuan, showing a year-on-year growth of 1.44% [2] - The basic earnings per share stood at 0.05 yuan [2] Financial Performance - Revenue for the reporting period was 229 million yuan, up 6.95% compared to the previous year [2] - Net profit attributable to shareholders was 16.71 million yuan, an increase of 7.74% year-on-year [2] - Non-recurring net profit was recorded at 8.89 million yuan, reflecting a growth of 1.44% year-on-year [2] - Basic earnings per share were reported at 0.05 yuan [2]

Financial Performance - The company reported a significant increase in revenue for the first half of 2025, achieving a total of 500 million yuan, representing a 25% growth compared to the same period last year[1]. - The company's operating revenue for the first half of 2025 reached RMB 228.78 million, representing a year-on-year increase of 6.95% compared to RMB 213.91 million in the same period last year[23]. - The total profit for the first half of 2025 was RMB 19.01 million, up 1.76% from RMB 18.68 million in the previous year[23]. - The net profit attributable to shareholders of the listed company was RMB 16.71 million, reflecting a 7.74% increase from RMB 15.51 million in the same period last year[23]. - The net cash flow from operating activities increased by 66.67%, amounting to RMB 20.30 million compared to RMB 12.18 million in the previous year[23]. - The comprehensive gross margin for the reporting period was 54.55%, indicating a strong profitability level[96]. - The company reported a total profit of ¥19,008,613.49 for the first half of 2025, compared to ¥18,679,722.49 in the same period of 2024, reflecting a growth of 1.8%[196]. - Net profit for the first half of 2025 was ¥16,713,493.27, representing a 7.7% increase from ¥15,512,643.35 in the first half of 2024[196]. Research and Development - Research and development expenditures have increased by 40%, totaling 50 million yuan, to support innovation in new technologies[1]. - The company's R&D expenditure accounted for 19.63% of operating revenue, an increase of 0.51 percentage points from 19.12% in the previous year[20]. - R&D investment reached 44.91 million yuan, a year-on-year growth of 9.82%, accounting for 19.63% of operating revenue[67]. - The company’s research and development activities are guided by market demand, focusing on high-performance, multifunctional nano-film technology[59]. - The number of R&D personnel increased to 244, representing 22.70% of the total workforce, up from 18.98% in the previous year[91]. Market Expansion and Strategy - The company is expanding its market presence in Southeast Asia, with plans to enter three new countries by the end of 2025[1]. - A strategic acquisition of a local competitor is anticipated to enhance the company's market share by 15% in the next fiscal year[1]. - The company has established subsidiaries in Shanghai and Wuhan to expand its market presence in the automotive and data communication sectors[70]. - The company is focusing on expanding into diverse downstream markets, including automotive electronics, medical devices, and new energy[66]. - The company has established a strategic partnership with Shanghai Shengyong International Trade Co., Ltd. to penetrate the high-end manufacturing market in Japan and South Korea, leveraging local advantages and expanding influence into Southeast Asia[71]. Product Development and Innovation - New product launches in the nano-technology sector are expected to contribute an additional 100 million yuan in revenue by Q4 2025[1]. - The company is establishing a global leading research and development center for nanomaterials and actively recruiting high-end experts in basic materials and plasma physics[32]. - The company has developed proprietary PECVD plasma polymerization technology, which integrates polymer material technology, low-temperature plasma technology, and nano vapor deposition technology, significantly enhancing its competitive edge in the nano film industry[33]. - The company has achieved breakthroughs in multiple coating technologies, including CVD, PECVD, and PVD, enhancing its position as a solution provider in the industry[46]. - The company has developed advanced plasma deposition technologies and has established a leading position in the nano-coating field, addressing protection issues for various electronic products and enhancing the competitiveness of China's electronics industry[78]. Risks and Challenges - The company has identified potential risks related to supply chain disruptions, which could impact production capacity in the upcoming quarters[1]. - The company faces risks related to rapid technological iterations in the nano-coating sector, which could impact its competitive edge[92]. - The company is exposed to risks from intensified industry competition and potential declines in downstream market demand due to macroeconomic factors[98]. - The company's reliance on external production models poses stability risks, particularly if client demand decreases or production sites face operational disruptions[94]. Governance and Compliance - The company maintains a strong governance structure, ensuring all financial reports are accurate and complete, with no significant risks identified during the reporting period[1]. - The board has approved a profit distribution plan, with no plans for capital increase through retained earnings for this period[1]. - The company has committed to strictly fulfill all public commitments disclosed in the prospectus and actively accept social supervision[150]. - The company’s board and senior management commit to not misappropriating company assets or engaging in unfair benefit transfers, ensuring adherence to compensation measures[16]. Shareholder and Stock Management - The company completed a share repurchase plan, acquiring 4,658,312 shares, representing 1.3886% of its total share capital, with a total expenditure of approximately RMB 50.2 million[76]. - The company has a lock-up period of 36 months for shares held before the IPO, during which no transfer or management delegation is allowed[122]. - The company commits to not transferring or managing its shares for 36 months post-IPO and cannot propose a buyback of those shares[130]. - The company’s major shareholders include FavoredTech and other entities holding over 5% of shares[121]. - The company’s core technical personnel are subject to specific shareholding restrictions post-IPO[120].

智通财经APP讯，菲沃泰(688371.SH)披露2025年半年度报告，报告期公司实现营收2.29亿元，同比增长 6.95%;归属于上市公司股东的净利润1671万元，同比增长7.74%;扣非净利润889万元，同比增长1.44%; 基本每股收益0.05元。 ...

Core Viewpoint - The company reported a revenue of 228.78 million yuan for the first half of the year, reflecting a year-on-year growth of 6.95% [1] - The net profit attributable to the parent company was 16.71 million yuan, an increase of 7.74% year-on-year [1] - The net profit excluding the impact of share-based payments reached 19.10 million yuan, up 8.92% year-on-year [1] Financial Performance - The company's operating cash flow net amount was 20.30 million yuan, showing a significant increase of 66.67% year-on-year [1] - Total assets at the end of the reporting period amounted to 2.03 billion yuan, a slight increase of 0.13% compared to the beginning of the period [1] - The net assets attributable to shareholders of the listed company were 1.92 billion yuan, reflecting a 1.00% increase from the beginning of the period [1] - The earnings per share attributable to the parent company was 5.72 yuan, which is a 1.00% increase from the beginning of the period [1]

Core Insights - The company reported a revenue of 229 million yuan for the first half of 2025, representing a year-on-year growth of 6.95% [1] - The net profit for the same period was 16.7135 million yuan, showing a year-on-year increase of 7.74% [1] Financial Performance - Revenue: 229 million yuan, up 6.95% year-on-year [1] - Net Profit: 16.7135 million yuan, up 7.74% year-on-year [1]